Wells Fargo’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Wells Fargo’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-129,688	Closed	-$2.42M	–	7992
2022 Q1	$2.42M	Sell	129,688 -76,144	-37%	-$1.37M	﹤0.01%	3117
2021 Q4	$4.4M	Buy	205,832 +36,501	+22%	+$719K	﹤0.01%	2705
2021 Q3	$3.13M	Sell	169,331 -1,312,151	-89%	-$26.4M	﹤0.01%	3276
2021 Q2	$31.7M	Buy	1,481,482 +130,714	+10%	+$2.66M	0.01%	1367
2021 Q1	$26.1M	Buy	+1,350,768	New	+$23.8M	0.01%	1453

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wells Fargo's OCDX Position: Q2 2022 in Review

Wells Fargo sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 129,688 shares — an estimated $2.42M sold.

Wells Fargo first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $31.7M in Q2 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Wells Fargo reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Wells Fargo sold 129,688 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $2.42M.
Wells Fargo first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Wells Fargo's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $31.7M in Q2 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Wells Fargo's 13F filing for Q2 2022, filed 12 Aug 2022.